These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20821187)

  • 1. Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice.
    Liu Y; Tanabe K; Baronnier D; Patel S; Woodgett J; Cras-Méneur C; Permutt MA
    Diabetologia; 2010 Dec; 53(12):2600-10. PubMed ID: 20821187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
    Tanabe K; Liu Z; Patel S; Doble BW; Li L; Cras-Méneur C; Martinez SC; Welling CM; White MF; Bernal-Mizrachi E; Woodgett JR; Permutt MA
    PLoS Biol; 2008 Feb; 6(2):e37. PubMed ID: 18288891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation.
    Liu Z; Tanabe K; Bernal-Mizrachi E; Permutt MA
    Diabetologia; 2008 Apr; 51(4):623-31. PubMed ID: 18219478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
    Fornoni A; Pileggi A; Molano RD; Sanabria NY; Tejada T; Gonzalez-Quintana J; Ichii H; Inverardi L; Ricordi C; Pastori RL
    Diabetologia; 2008 Feb; 51(2):298-308. PubMed ID: 18066521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
    Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
    Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
    Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
    Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice.
    Shojima N; Hara K; Fujita H; Horikoshi M; Takahashi N; Takamoto I; Ohsugi M; Aburatani H; Noda M; Kubota N; Yamauchi T; Ueki K; Kadowaki T
    Diabetologia; 2012 Dec; 55(12):3318-30. PubMed ID: 22983607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats.
    Figeac F; Uzan B; Faro M; Chelali N; Portha B; Movassat J
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E245-56. PubMed ID: 19920216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
    Sampath C; Srinivasan S; Freeman ML; Gangula PR
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G481-G493. PubMed ID: 32812777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
    Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
    J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity.
    Henriksen EJ; Teachey MK; Lindborg KA; Diehl CJ; Beneze AN
    Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1813-21. PubMed ID: 18385470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3β.
    Wohua Z; Weiming X
    Biomed Pharmacother; 2019 Oct; 118():108940. PubMed ID: 31382130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.
    Desai SS; Modali SD; Parekh VI; Kebebew E; Agarwal SK
    J Biol Chem; 2014 Feb; 289(9):5386-98. PubMed ID: 24425879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation.
    Velazquez-Garcia S; Valle S; Rosa TC; Takane KK; Demirci C; Alvarez-Perez JC; Mellado-Gil JM; Ernst S; Scott DK; Vasavada RC; Alonso LC; Garcia-Ocaña A
    Diabetes; 2011 Oct; 60(10):2546-59. PubMed ID: 21911744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span.
    Gillespie JR; Bush JR; Bell GI; Aubrey LA; Dupuis H; Ferron M; Kream B; DiMattia G; Patel S; Woodgett JR; Karsenty G; Hess DA; Beier F
    Endocrinology; 2013 Oct; 154(10):3702-18. PubMed ID: 23904355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
    Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
    Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.